Collaborative research the effectiveness of BEGINNINGS®.
PHYSICANS PROFESSIONAL MARKETING GROUP LLC.
Objective:
The primary goal of the study is to evaluate the effect of Beginnings® on the appearance of fine lines, wrinkles and hypo-pigmentation (FlWHh).
DESIGN, SETTING, AND PATIENTS:
The Study on Beginnings® and fine lines, wrinkles and hypo-pigmentation (FlWHh) was a randomized, placebo-controlled. A total of 100 individuals with varying degrees of visible wrinkles, visible lines and/or hypo-pigmentation were selected. Patients were randomly assigned to receive a treatment of Beginnings ® (n = 50) or placebo (n 50). The groups were compared immediately after the application and at the end of the 21 day trial and total of 9 applications. MAIN OUTCOME MEASURE, RESULTS: The primary decrease in appearance of FlWHh after the first application appeared in 47 (94%) patients taking Beginnings ® vs. 8 (16%) patients taking placebo. In comparison after the 21days, analyses showed reduced appearance of FlWHh to 49 (98%) vs. the placebo 13 (26%) CONCLUSION: Our findings indicate evidence of a strong association between Beginnings® and decrease of FlWHh.
Methodology
Exclusion Criteria: None
Randomization: Individuals enrolled in the study were assigned to the tested product Group or the Placebo Skin Care Group according to a randomization sequence using sealed envelopes.
Study Intervention
Test Group
The powder was gently applied to the face according to instructions. Immediate changes were recorded. Initial application was followed by 8 applications in the period of 21 days.
Control Group
The placebo was gently applied to the face in identical fashion as the test group. Immediate changes were recorded. Initial application was followed by 8 applications in the period of 21 days.
DATA COLLECTION
Data was collected to address the primary and secondary outcomes as well as other possible variables in specific Study Forms. Additional information was collected from all participants, in a standard form used for continuous monitoring of results if deemed necessary.
STUDY SPONSORS
This clinical study has been sponsored by DRRI International®.
